World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
55659
World Ranking
5910
National Ranking
581

Overview

Christopher J. Hawkey is affiliated with the University of Nottingham in the United Kingdom and has a research focus primarily within the field of Medicine. Their work spans multiple subfields including Surgery, Gastroenterology, Genetics, Epidemiology, and Cardiology and Cardiovascular Medicine.

The scientist has contributed to several notable topics, including:

  • Helicobacter pylori-related gastroenterology studies
  • Inflammatory Bowel Disease
  • Autoimmune and Inflammatory Disorders
  • Gastroesophageal reflux and treatments
  • Gastric Cancer Management and Outcomes
  • Autoimmune and Inflammatory Disorders Research
  • Antiplatelet Therapy and Cardiovascular Diseases

Their publication record reflects a focus on clinical trials and disease management, with frequent appearances in venues such as The Lancet, Health Technology Assessment, and The Lancet Gastroenterology & Hepatology, among others.

Recent publications by Christopher J. Hawkey include:

  • Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial, 2022, The Lancet
  • Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial, 2024, The Lancet. Gastroenterology & Hepatology
  • Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation, 2024, Health Technology Assessment
  • OFR-9 An RCT of autologous stem-cell transplantation in treatment refractory Crohn's disease (low-intensity therapy evaluation): ASTIClite, 2021, Oral
  • Eradication of Helicobacter pylori for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCT, 2025, Health Technology Assessment

Christopher J. Hawkey has collaborated frequently with colleagues including Anthony Avery, Jennifer Dumbleton, Carol Coupland, Colin Crooks, and Denise Kendrick.

Their work spans various forms of clinical research with a focus on gastrointestinal diseases, cardiovascular medicine, and inflammatory conditions. The range of publication venues and coauthors illustrates an active engagement with the medical research community in their specialized fields.

Best Publications

  • Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

    Luke Jostins;Stephan Ripke;Rinse K Weersma;Richard H Duerr

  • Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

    Claire Bombardier;Loren Laine;Alise Reicin;Deborah Shapiro

  • COX-2 inhibitors

    CJ Hawkey

  • Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease

    Katrina M de Lange;Loukas Moutsianas;James C Lee;Christopher A Lamb

  • Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials

    Colin Baigent;N. Bhala;J. Emberson;A. Merhi

  • Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.

    David Henry;Lynette L.Y. Lim;Luis A. Garcia Rodriguez;Susanne Perez Gutthann

  • Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs

    Christopher J. Hawkey;Jeffrey A. Karrasch;Leszek Szczepanski;Donald G. Walker

  • A Comparison of Omeprazole with Ranitidine for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs

    N D Yeomans;Z Tulassay;L Juhász;I Rácz

  • Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

    Thomas J Schnitzer;Gerd R Burmester;Eduardo Mysler;Marc C Hochberg

  • Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

    Michael E. Farkouh;Howard Kirshner;Robert A. Harrington;Sean Ruland

  • European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

    R. Caprilli;M. A. Gassull;J. C. Escher;G. Moser

  • Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.

    Ali S. Taha;Nicholas Hudson;Christopher J. Hawkey;Anthony J. Swannell

  • Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

    A. B. Hawthorne;R. F. A. Logan;C. J. Hawkey;P. N. Foster

  • Nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

    N.K. Boughton-Smith;S.M. Evans;B.J.R. Whittle;S. Moncada

  • Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

    Nicholas A Kennedy;Nicholas A Kennedy;Nicholas A Kennedy;Graham A Heap;Harry D Green;Benjamin Hamilton

  • Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease.

    W A Stack;S D Mann;A J Roy;P Heath

  • Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study

    C. J. Hawkey;Z. Tulassay;L. Szczepanski;C. J. van Rensburg

  • Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial

    Christopher Hawkey;Loren Laine;Thomas Simon;Andre Beaulieu

  • Prostaglandins and the gastrointestinal mucosa: Are they important in its function, disease, or treatment?

    C.J. Hawkey;D.S. Rampton

  • Nonsteroidal anti-inflammatory drug gastropathy

    Christopher J. Hawkey

Frequent Co-Authors

John Atherton
John Atherton Royal Brisbane and Women's Hospital
Jack Satsangi
Jack Satsangi University of Oxford
Angel Lanas
Angel Lanas University of Zaragoza
Gerhard Rogler
Gerhard Rogler University of Zurich
Roger Jones
Roger Jones King's College London
Myriam Labopin
Myriam Labopin Université Paris Cité
Nicholas J. Talley
Nicholas J. Talley University of Newcastle Australia
Simon Travis
Simon Travis University of Oxford
Loren Laine
Loren Laine Yale University
Tariq Ahmad
Tariq Ahmad Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering Medical studies in the USA opens the door to a variety of online degree options and career pathways. For those already in nursing or seeking a flexible educational route, online programs offer affordability and convenience. Many students search for the cheapest fnp programs online to become Family Nurse Practitioners, which remains a high-demand field with strong salary potential.

If you are an RN aiming to boost your credentials but need to watch your budget, exploring rn to bsn online cost comparisons can help you find wallet-friendly options. Those interested in leadership, research, or teaching roles might consider a Doctorate in Nursing Practice and look for the cheapest dnp programs.

For nurses seeking advanced practice or management, seeking out the cheapest online msn programs can be a smart move. With a range of accredited online programs now available, pursuing the next step in your healthcare career is more accessible—and affordable—than ever.

Best Scientists Citing Christopher J. Hawkey

Trending Scientists